IPHARMA at the All-Russian Pharmaceutical Congress

On 25th of July, the All-Russian Pharmaceutical Congress “Pharmaceutical activity in Russia and the EAEU: statutory regulation for summer 2018” was held in Moscow.


The event was supported by the State Duma of the Federal Assembly of the Russian Federation, the Ministry of Economic Development of the Russian Federation, the Chamber of Commerce and Industry of the Russian Federation, The Ministry of Natural Resources and Environment of the Russian Federation, The Ministry of Regional Development of the Russian Federation, the Ministry of Health of the Russian Federation and others.


The program was focused on the questions of pharmacological activity regulation in Russia and EAEU, and also control in drug market and protection of intellectual property.


At the congress, IPHARMA members presented their reports:


Natalia Vostokova, PhD, Chief operating officer

Julia Trakhtenberg, PhD, Medical director


Topics:


“Preclinical and clinical trials: current issues of regulation in 2018”


“Use of IT technologies: a new way to lower the expenses in clinical trials”


“Actual questions of pharmacovigilance in Russia and the EAEU”


IPHARMA thanks the organizers of the congress. We were glad to discuss the topical issues of clinical trials organization and conduct among industry professionals and to share our experience of successful realization of research projects.



Недавние посты
Архив